Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 54 clinical trials
featured
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also

carbidopa
levodopa
  • 102 views
  • 23 Nov, 2020
  • 1 location
featured
Neurovascular effects of dopamine replacement therapy in Parkinson's disease

The goal of this research study is to understand the evolution of levodopa-induced dyskinesias (LID), a refractory and disabling side effect of the gold standard treatment of Parkinson's disease

carbidopa
levodopa
  • 97 views
  • 13 Aug, 2020
  • 1 location
featured
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the

illicit drug
  • 54 views
  • 23 Nov, 2020
  • 1 location
featured
Parkinson's Disease Study at Wake Research

and Drug Administration [FDA] in the USA as an example). ABBV-951 is a formulation of carbidopa and levodopa, which are medications commonly used to treat symptoms in PD.

carbidopa
motor symptoms
levodopa
  • 75 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson’s Disease Patients

A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa

  • 342 views
  • 08 Nov, 2020
  • 1 location
featured
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease Experiencing End of Dose "Wearing-Off" (TOZ-PD)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated

  • 222 views
  • 23 Nov, 2020
  • 1 location
featured
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

  • 886 views
  • 08 Nov, 2020
  • 2 locations
featured
Open Label Parkinson's clinical research study

Open Label Parkinson's clinical research study

  • 568 views
  • 25 Mar, 2021
  • 1 location
featured
Do you have Parkinson’s disease?

Do you have Parkinson’s disease?

  • 254 views
  • 08 Nov, 2020
  • 1 location
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

This study aims to determine whether levodopa is effective in boosting learning and memory in healthy subjects and patients with dementia or Mild Cognitive Impairment. We also examine in

cognitive impairment
dementia
mild cognitive impairment
  • 36 views
  • 07 Nov, 2020
  • 1 location